Home | Sitemap | Search | Contact

A- A A+

English

Public

Member

Support us

Home

Sitemap

Pictures
Member
Public
- About IBCSG
  - Group Structure
  - IBCSG Members
    - Australia
    - Belgium
    - Brazil
    - Chile
    - Hungary
    - India
    - Italy
    - New Zealand
    - Nigeria
    - Peru
    - Romania
    - Slovenia
    - South Africa
    - Spain
    - Sweden
    - Switzerland
  - IBCSG Publications
  - Research Network
- Patients & Public
  - IBCSG Clinical Trials
    - Open Trials
- Health Professionals
  - Open Trials
  - Closed Trials
    - Trial I
    - Trial II
    - Trial III
    - Trial IV
    - Trial V
    - Trial VI
    - Trial VII
    - Trial VIII
    - Trial IX
    - IBCSG 10-93
    - IBCSG 11-93
    - IBCSG 12-93
    - IBCSG 13-93
    - IBCSG 14-93
    - IBCSG 15-95
    - IBCSG 16-98
    - IBCSG 17-98
    - IBCSG 18-98
    - IBCSG 19-01
    - IBCSG 20-98
    - IBCSG 21-99
    - IBCSG 26-02
    - IBCSG 28-02
    - IBCSG 29-03
    - IBCSG 30-04
    - IBCSG 32-05
    - IBCSG 33-03
- Tissue Bank / Translational Research
  - Research
  - Central Pathology Office
News
Support us

News

18.06.2010:
CMF chemotherapy is effective for triple-negative, node-negative breast cancer in IBCSG Trials VIII

05.05.2010:
A few impressions from our audits

27.01.2010:
First issue of SOLE flash, the short newsletter for IBCSG 35-07 SOLE

Print

Disclaimer | Copyright